Transdermal estradiol therapy for prostate cancer reduces thrombophilic activation and protects against thromboembolism (Q34432715)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Transdermal estradiol therapy for prostate cancer reduces thrombophilic activation and protects against thromboembolism
scientific article

    Statements

    Transdermal estradiol therapy for prostate cancer reduces thrombophilic activation and protects against thromboembolism (English)
    527-33; discussion 532-3

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit